The nucleus basalis of Meynert: A new target for deep brain stimulation in dementia?

@article{Gratwicke2013TheNB,
  title={The nucleus basalis of Meynert: A new target for deep brain stimulation in dementia?},
  author={James Gratwicke and Joshua Kahan and Ludvic U. Zrinzo and Marwan I. Hariz and Patricia Limousin and Thomas Foltynie and Marjan Jahanshahi},
  journal={Neuroscience \& Biobehavioral Reviews},
  year={2013},
  volume={37},
  pages={2676-2688}
}
Dementia is a major cause of disability amongst the elderly and represents a serious global health issue. Current treatments for dementia are limited; at best they provide inadequate symptomatic relief. In contrast, there are a plethora of approaches that provide symptomatic relief for abnormalities of movement including surgical approaches. Deep brain stimulation has been used successfully to directly alter processing in neural networks and thereby improve movement functions. Here we describe… Expand
Can deep brain stimulation of the nucleus basalis of Meynert improve thinking and memory problems in Lewy body dementias
The Lewy body dementias, Parkinson’s disease dementia and dementia with Lewy bodies, are two of the most common causes of dementia worldwide, and share both a common clinical phenotype and underlyingExpand
Deep Brain Stimulation in Alzheimer's Disease: Targeting the Nucleus Basalis of Meynert.
TLDR
As a critical component of the cerebral cholinergic system and the Papez circuit in the basal ganglia, the NBM plays an indispensable role in the subcortical regulation of memory, attention, and arousal state, which makes the N BM a promising target for modulation of neural network dysfunction and AD treatment. Expand
Nucleus Basalis of Meynert Stimulation for Dementia: Theoretical and Technical Considerations
Deep brain stimulation (DBS) of nucleus basalis of Meynert (NBM) is currently being evaluated as a potential therapy to improve memory and overall cognitive function in dementia. Although, the animalExpand
Bilateral Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson Disease Dementia: A Randomized Clinical Trial
TLDR
Low-frequency NBM DBS was safely conducted in patients with Parkinson disease dementia; however, no improvements were observed in the primary cognitive outcomes or in results of resting state functional magnetic resonance imaging. Expand
Electrical stimulation of the nucleus basalis of meynert: a systematic review of preclinical and clinical data
TLDR
Preclinical and clinical data on the design of NBM stimulation experiments and its effects on behavioral and neurophysiological aspects are systematically reviewed here. Expand
Deep Brain Stimulation as a Tool for Improving Cognitive Functioning in Alzheimer’s Dementia: A Systematic Review
TLDR
This review describes three studies investigating the effects of DBS in patients with dementia, using either the fornix or the nucleus basalis of Meynert (NBM) as a target. Expand
Deep brain stimulation for dementias.
TLDR
For future studies to have adequate power to detect meaningful clinical changes, further refinement is needed in patient selection, metrics of clinical response, and optimal stimulation parameters. Expand
Deep Brain Stimulation for Disorders of Memory and Cognition
TLDR
A global experience is now emerging for the use of DBS for these conditions, targeting key nodes in the memory circuit, including the fornix and nucleus basalis of Meynert, holding promise as a novel therapeutic approach for one of medicine’s most urgent priorities. Expand
Cortical connectivity of the nucleus basalis of Meynert in Parkinson’s disease and Lewy body dementias
TLDR
Functional networks of the NBM are revealed that are likely to subserve important roles in motor control, memory and visual function, respectively and motivate future studies aimed at disentangling network contribution to disease phenotype. Expand
Deep Brain Stimulation of the Memory Circuit: Improving Cognition in Alzheimer's Disease.
TLDR
All completed and ongoing human studies of DBS in Alzheimer's disease are summarized, and a pro-cognitive effect mediated by changes on cellular as well as network level is uncovered. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 190 REFERENCES
Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation.
TLDR
A broad effect on cognition is consistent with ample experimental evidence revealing that the nucleus basalis of Meynert provides cholinergic innervation to the cortical mantle, complemented by glutaminergic and gamma-aminobutyric acid-transmitting projections from the basal forebrain. Expand
Stimulation of the basal nucleus of Meynert in senile dementia of Alzheimer's type. A preliminary report.
TLDR
A follow-up positron emission tomography scan shows that cortical glucose metabolic activity was preserved in the ipsilateral temporal and parietal lobes while it declined elsewhere in the cortex. Expand
Deep brain stimulation for the treatment of Alzheimer disease and dementias.
TLDR
Evidence for the use of DBS to treat dementia is preliminary and limited, and fornix and nucleus basalis of Meynert DBS can influence activity in the pathologic neural circuits that underlie AD and Parkinson disease dementia. Expand
Pathological changes in the nucleus of meynert in Alzheimer's and Parkinson's diseases
TLDR
Observations, together with major differences in the neuropathology of the nucleus in SDAT and Parkinson's disease (neurofibrillary tangle and Lewy body formation, respectively) suggest that the involvement of the cholinergic system may differ in the two disease processes. Expand
Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
TLDR
The findings suggest that signal changes occur in patients with Alzheimer's disease in the substantia innominata which may be related to the loss or degeneration of cholinergic neurones and correspond to regional cortical grey matter atrophy. Expand
Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease.
TLDR
Findings establish, for the first time, a link between degeneration of specific cholinergic compartments of the BFCS and cognitive-related deficits in subjects at high risk of developing AD. Expand
The cholinergic system in mild cognitive impairment and Alzheimer's disease: An in vivo MRI and DTI study
TLDR
The findings suggest that a multimodal MRI‐DTI approach is supportive to determine atrophy of cholinergic nuclei and its effect on intracortical projecting fiber tracts in AD. Expand
Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction
TLDR
Observations indicate the complexity of the chemoanatomy of the human CBF and suggest that multiple factors play different roles in its dysfunction in aging and AD. Expand
Rivastigmine for dementia associated with Parkinson's disease.
TLDR
Rivastigmine was associated with moderate improvements in dementia associated with Parkinson's disease but also with higher rates of nausea, vomiting, and tremor; however, the differences between these two groups were moderate and similar to those reported in trials of rivastIGmine for Alzheimer's disease. Expand
Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia
TLDR
It is concluded that cortical cholinergic denervation in PD and parkinsonian dementia is associated with decreased performance on tests of attentional and executive functioning. Expand
...
1
2
3
4
5
...